Product Information

NIVA THYROID 30 MG TABLET is a generic product labeled by Nivagen Pharmaceuticals Inc., priced at $0.5951 per EA under NDC 75834031101. Its NADAC has been published 137 times since Nov 15, 2023.

NIVA THYROID 30 MG TABLET

thyroid, porcine
$0.5951per EA

Strength

30 mg/1

NDC

75834031101

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

6/17/2026

Active Ingredients

THYROID

Approval Type

Unapproved

On Market Since

7/24/2023

Price Statistics

The NADAC for NIVA THYROID 30 MG TABLET has been published 137 times since Nov 15, 2023, and over the history we have for it it has declined 6.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.5951 per EA
All-time high$0.6535 (Feb 14, 2024)
All-time low$0.5358 (Nov 20, 2024)
52-week high$0.6219
52-week low$0.5717
Median price$0.5965
Average price$0.5994
Largest weekly change-14.5% (Apr 17, 2024)
Weeks tracked137
Tracking sinceNov 15, 2023

Price History

1W

0.0%

1M

+1.3%

3M

+0.6%

6M

+1.7%

1Y

-4.3%

3Y

N/A

5Y

N/A

All

-6.0%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the thyroid, porcine market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Frequently asked questions

What is the NADAC price of NIVA THYROID 30 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for NIVA THYROID 30 MG TABLET, manufactured by Nivagen Pharmaceuticals Inc., is $0.5951 per EA (NDC 75834031101), effective Jun 24, 2026.

How has the price of NIVA THYROID 30 MG TABLET changed over time?

Over the history we have for it, the NADAC for NIVA THYROID 30 MG TABLET has declined 6.0%. It has been tracked across 137 weekly CMS publications since Nov 15, 2023.

What are the highest and lowest recorded NADAC prices for NIVA THYROID 30 MG TABLET?

Since Nov 15, 2023, the NADAC for NIVA THYROID 30 MG TABLET has ranged from a low of $0.5358 (Nov 20, 2024) to a high of $0.6535 (Feb 14, 2024), with a median of $0.5965 per EA.

Are there cheaper alternatives to NIVA THYROID 30 MG TABLET?

No other NADAC-published product currently shares the active ingredient, strength, and dosage form of NIVA THYROID 30 MG TABLET, so no direct lower-cost alternative is listed.

Who manufactures NIVA THYROID 30 MG TABLET?

NIVA THYROID 30 MG TABLET (NDC 75834031101) is labeled by Nivagen Pharmaceuticals Inc., and CMS classifies it as a generic product.

Related Drugs

Same classification

No related drugs found.